Analysis: Minimally Invasive Lower-Back Treatments Lack Good Data For Comparison
This article was originally published in The Gray Sheet
Executive Summary
The scarcity of randomized data for device lower-back pain treatments limits comparisons of their clinical effectiveness and value, researchers conclude in a recent report.
You may also be interested in...
Increased CDRH Post-Approval Vigilance Plays Out In Medtronic X-Stop Trials
Medtronic clinical executive Ruchir Sehra says CDRH's newfound rigor in the postmarket area is evident in its approach to the firm's post-approval study of the X-Stop spinal implant
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.